CNR1 and fatty liver disease: Stimulating CB1R with specific agonists increases the secretion of insulin, somatostatin, and glucagon; it increases fat storage by stimulating lipoprotein lipase and release of adiponectin, and as a result, hepatic steatosis and IR develop.